Growth Metrics

HeartSciences (HSCS) Cash & Current Investments (2022 - 2026)

HeartSciences filings provide 5 years of Cash & Current Investments readings, the most recent being $3.4 million for Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 30.83% to $3.4 million in Q1 2026 year-over-year; TTM through Jan 2026 was $3.4 million, a 30.83% increase, with the full-year FY2025 number at $1.1 million, down 81.07% from a year prior.
  • Cash & Current Investments hit $3.4 million in Q1 2026 for HeartSciences, up from $2.0 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $7.1 million in Q1 2024 to a low of $100144.0 in Q4 2023.
  • Median Cash & Current Investments over the past 5 years was $2.7 million (2025), compared with a mean of $2.9 million.
  • Biggest five-year swings in Cash & Current Investments: plummeted 96.74% in 2023 and later skyrocketed 3946.29% in 2024.
  • HeartSciences' Cash & Current Investments stood at $3.1 million in 2022, then plummeted by 96.74% to $100144.0 in 2023, then skyrocketed by 3946.29% to $4.1 million in 2024, then plummeted by 51.85% to $2.0 million in 2025, then skyrocketed by 74.11% to $3.4 million in 2026.
  • The last three reported values for Cash & Current Investments were $3.4 million (Q1 2026), $2.0 million (Q4 2025), and $2.8 million (Q3 2025) per Business Quant data.